<p>Data are number (%), unless otherwise indicated.</p><p>*Treatment outcome definitions used are WHO definitions, as defined in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0094016#pone-0094016-t004" target="_blank">Table 4</a>.</p
BACKGROUND: Simplified drug-resistant tuberculosis (DR-TB) treatment outcome definitions, mostly cen...
<p>Treatment outcomes of 669 patients enrolled in individualized treatment for MDR-TB in Peru betwee...
OBJECTIVE: Evidence on treatment outcomes and their trend analysis through a register based retrospe...
<p>Treatment outcomes of patients with MDR-TB in KwaZulu-Natal, South Africa (N = 1038).</p
<p>*Treatment outcome definitions used are WHO definitions for the management of MDR-TB. <a href="ht...
Setting—In KwaZulu-Natal, South Africa, a TB and HIV endemic setting, prolonged hospitalisation for ...
<p>Overall treatment outcome of MDR-TB patients at public hospitals in the Amhara Regional State, Se...
<p>Treatment outcomes among HIV-infected multi-drug resistant tuberculosis patients and access to AR...
PURPOSE: Multidrug-resistant tuberculosis (MDR-TB) is associated with lengthy treatment, expensive a...
a<p>Table values are median (IQR) for continuous variables and n (column %) for categorical variable...
Background: The World Health Organization target is to reduce to zero the number of death due to Myc...
Treatment outcome among TB patients commenced on treatment, Mimika district, 2014–2020.</p
<p>*Transferred out and not recorded 10</p><p><sup>#</sup>Not recorded 2</p><p>MDR-TB treatment outc...
Multidrug-resistant tuberculosis (MDR-TB) is a major clinical challenge, particularly in patients wi...
Background: Developing countries like India are heavily burdened with multidrug resistant tuberculos...
BACKGROUND: Simplified drug-resistant tuberculosis (DR-TB) treatment outcome definitions, mostly cen...
<p>Treatment outcomes of 669 patients enrolled in individualized treatment for MDR-TB in Peru betwee...
OBJECTIVE: Evidence on treatment outcomes and their trend analysis through a register based retrospe...
<p>Treatment outcomes of patients with MDR-TB in KwaZulu-Natal, South Africa (N = 1038).</p
<p>*Treatment outcome definitions used are WHO definitions for the management of MDR-TB. <a href="ht...
Setting—In KwaZulu-Natal, South Africa, a TB and HIV endemic setting, prolonged hospitalisation for ...
<p>Overall treatment outcome of MDR-TB patients at public hospitals in the Amhara Regional State, Se...
<p>Treatment outcomes among HIV-infected multi-drug resistant tuberculosis patients and access to AR...
PURPOSE: Multidrug-resistant tuberculosis (MDR-TB) is associated with lengthy treatment, expensive a...
a<p>Table values are median (IQR) for continuous variables and n (column %) for categorical variable...
Background: The World Health Organization target is to reduce to zero the number of death due to Myc...
Treatment outcome among TB patients commenced on treatment, Mimika district, 2014–2020.</p
<p>*Transferred out and not recorded 10</p><p><sup>#</sup>Not recorded 2</p><p>MDR-TB treatment outc...
Multidrug-resistant tuberculosis (MDR-TB) is a major clinical challenge, particularly in patients wi...
Background: Developing countries like India are heavily burdened with multidrug resistant tuberculos...
BACKGROUND: Simplified drug-resistant tuberculosis (DR-TB) treatment outcome definitions, mostly cen...
<p>Treatment outcomes of 669 patients enrolled in individualized treatment for MDR-TB in Peru betwee...
OBJECTIVE: Evidence on treatment outcomes and their trend analysis through a register based retrospe...